Cost–Benefit Analysis of in vivo Reflectance Confocal Microscopy for Melanoma Diagnosis in a Real-World Clinical Setting
Giacomo Matteo Bruno,1 Sergio Di Matteo,2 Caterina Longo,3,4,* Ignazio Stanganelli,5,6,* Francesca Farnetani,7 Stefania Borsari,3 Laura Mazzoni,5 Silavana Ciardo,7 Margherita Raucci,3 Serena Magi,5 Sara Bassoli,7 Marco Spadafora,3,8 Victor Desmond Mandel,9 Alice Casari,7 Johanna Ches...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-01-01
|
| Series: | Risk Management and Healthcare Policy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/costbenefit-analysis-of-in-vivo-reflectance-confocal-microscopy-for-me-peer-reviewed-fulltext-article-RMHP |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841526594351398912 |
|---|---|
| author | Bruno GM Di Matteo S Longo C Stanganelli I Farnetani F Borsari S Mazzoni L Ciardo S Raucci M Magi S Bassoli S Spadafora M Mandel VD Casari A Chester J Kaleci S Colombo GL Pellacani G |
| author_facet | Bruno GM Di Matteo S Longo C Stanganelli I Farnetani F Borsari S Mazzoni L Ciardo S Raucci M Magi S Bassoli S Spadafora M Mandel VD Casari A Chester J Kaleci S Colombo GL Pellacani G |
| author_sort | Bruno GM |
| collection | DOAJ |
| description | Giacomo Matteo Bruno,1 Sergio Di Matteo,2 Caterina Longo,3,4,* Ignazio Stanganelli,5,6,* Francesca Farnetani,7 Stefania Borsari,3 Laura Mazzoni,5 Silavana Ciardo,7 Margherita Raucci,3 Serena Magi,5 Sara Bassoli,7 Marco Spadafora,3,8 Victor Desmond Mandel,9 Alice Casari,7 Johanna Chester,7 Shaniko Kaleci,7 Giorgio Lorenzo Colombo,10 Giovanni Pellacani11 1Department of Drug Sciences, University of Pavia, Pavia, Italy; 2S.A.V.E. Studi Analisi Valutazioni Economiche S.r.l., Health Economics & Outcomes Research, Milan, Italy; 3Azienda Unità Sanitaria Locale – IRCCS di Reggio Emilia, Skin Cancer Center, Reggio Emilia, Italy; 4Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy; 5Skin Cancer Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy; 6Department of Medicine and Surgery, University of Parma, Parma, Italy; 7Dermatology Unit, Department of Surgical, Medical, Dental & Morphological Sciences with Interest Transplant, Oncological & Regenerative Medicine, University of Modena and Reggio Emilia, Modena, 41125, Italy; 8Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy; 9Porphyria and Rare Diseases Unit, San Gallicano Dermatological Institute-IRCCS, Roma, Italy; 10Department of Drug Sciences, CEFAT-Center of Pharmaceuticals Economics and Medical Technologies Evaluation, University of Pavia, Pavia, Italy; 11Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Dermatology Clinic, Sapienza University of Rome, Rome, Italy*These authors contributed equally to this workCorrespondence: Giacomo Matteo Bruno, Department of Drug Sciences, University of Pavia, Pavia, Italy, Email giacomomatteo.bruno@unipv.itBackground: In a recent prospective, multicenter, two-arm randomized controlled trial (RCT), we demonstrated that adjunctive reflectance confocal microscopy (RCM) in routine clinical practice provides clinical benefits, including safe melanoma detection and a 43.3% reduction in the number needed to excise (NNE).Methods: A cost–benefit analysis was conducted based on NNEs for standard care (5.3) and adjunctive RCM (3.0). Cost data were supplied by one center, applying a micro-costing approach from the hospital’s perspective. Costs were calculated for dermatology exams, excisions, medications, histopathology, and follow-up. The outcomes were extrapolated to provincial and national settings to assess the economic benefits of RCM.Results: The cost per patient for standard care was € 143.63, compared to € 114.74 for adjunctive RCM. The cost per melanoma excised with standard care (NNE 5.3) was € 904.87, almost twice the cost for RCM (€ 458.96). Annual regional and national costs for standard care were € 864,150.85 and € 11,491,849.00, respectively, while RCM reduced these to € 438,306.80 and € 5,828,792.00. Estimated annual savings with adjunctive RCM were € 425,844.05 regionally and € 5,663,057.00 nationally. The cost–benefit ratio for RCM was 3.89, meaning that for every € 1 spent on RCM, there is a benefit of € 3.89.Conclusion: In real-world clinical practice, adjunctive RCM offers significant economic advantages at local, regional, and national levels while maintaining patient safety and reducing unnecessary surgical procedures.Keywords: melanoma, dermoscopic examination, reflectance confocal microscopy, cost–benefit, economics, cost analysis, skin cancers |
| format | Article |
| id | doaj-art-b6080052763f49a894e99fd7111f4221 |
| institution | Kabale University |
| issn | 1179-1594 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Risk Management and Healthcare Policy |
| spelling | doaj-art-b6080052763f49a894e99fd7111f42212025-01-16T16:17:13ZengDove Medical PressRisk Management and Healthcare Policy1179-15942025-01-01Volume 1816317299248Cost–Benefit Analysis of in vivo Reflectance Confocal Microscopy for Melanoma Diagnosis in a Real-World Clinical SettingBruno GMDi Matteo SLongo CStanganelli IFarnetani FBorsari SMazzoni LCiardo SRaucci MMagi SBassoli SSpadafora MMandel VDCasari AChester JKaleci SColombo GLPellacani GGiacomo Matteo Bruno,1 Sergio Di Matteo,2 Caterina Longo,3,4,* Ignazio Stanganelli,5,6,* Francesca Farnetani,7 Stefania Borsari,3 Laura Mazzoni,5 Silavana Ciardo,7 Margherita Raucci,3 Serena Magi,5 Sara Bassoli,7 Marco Spadafora,3,8 Victor Desmond Mandel,9 Alice Casari,7 Johanna Chester,7 Shaniko Kaleci,7 Giorgio Lorenzo Colombo,10 Giovanni Pellacani11 1Department of Drug Sciences, University of Pavia, Pavia, Italy; 2S.A.V.E. Studi Analisi Valutazioni Economiche S.r.l., Health Economics & Outcomes Research, Milan, Italy; 3Azienda Unità Sanitaria Locale – IRCCS di Reggio Emilia, Skin Cancer Center, Reggio Emilia, Italy; 4Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy; 5Skin Cancer Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy; 6Department of Medicine and Surgery, University of Parma, Parma, Italy; 7Dermatology Unit, Department of Surgical, Medical, Dental & Morphological Sciences with Interest Transplant, Oncological & Regenerative Medicine, University of Modena and Reggio Emilia, Modena, 41125, Italy; 8Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy; 9Porphyria and Rare Diseases Unit, San Gallicano Dermatological Institute-IRCCS, Roma, Italy; 10Department of Drug Sciences, CEFAT-Center of Pharmaceuticals Economics and Medical Technologies Evaluation, University of Pavia, Pavia, Italy; 11Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Dermatology Clinic, Sapienza University of Rome, Rome, Italy*These authors contributed equally to this workCorrespondence: Giacomo Matteo Bruno, Department of Drug Sciences, University of Pavia, Pavia, Italy, Email giacomomatteo.bruno@unipv.itBackground: In a recent prospective, multicenter, two-arm randomized controlled trial (RCT), we demonstrated that adjunctive reflectance confocal microscopy (RCM) in routine clinical practice provides clinical benefits, including safe melanoma detection and a 43.3% reduction in the number needed to excise (NNE).Methods: A cost–benefit analysis was conducted based on NNEs for standard care (5.3) and adjunctive RCM (3.0). Cost data were supplied by one center, applying a micro-costing approach from the hospital’s perspective. Costs were calculated for dermatology exams, excisions, medications, histopathology, and follow-up. The outcomes were extrapolated to provincial and national settings to assess the economic benefits of RCM.Results: The cost per patient for standard care was € 143.63, compared to € 114.74 for adjunctive RCM. The cost per melanoma excised with standard care (NNE 5.3) was € 904.87, almost twice the cost for RCM (€ 458.96). Annual regional and national costs for standard care were € 864,150.85 and € 11,491,849.00, respectively, while RCM reduced these to € 438,306.80 and € 5,828,792.00. Estimated annual savings with adjunctive RCM were € 425,844.05 regionally and € 5,663,057.00 nationally. The cost–benefit ratio for RCM was 3.89, meaning that for every € 1 spent on RCM, there is a benefit of € 3.89.Conclusion: In real-world clinical practice, adjunctive RCM offers significant economic advantages at local, regional, and national levels while maintaining patient safety and reducing unnecessary surgical procedures.Keywords: melanoma, dermoscopic examination, reflectance confocal microscopy, cost–benefit, economics, cost analysis, skin cancershttps://www.dovepress.com/costbenefit-analysis-of-in-vivo-reflectance-confocal-microscopy-for-me-peer-reviewed-fulltext-article-RMHPmelanomaskin cancerdiagnosisnon-invasive diagnosisimaging techniquesskin imagingreflectance confocal microscopydermatoscopydermoscopynumber needed to excisefollow-uprandomized trial. |
| spellingShingle | Bruno GM Di Matteo S Longo C Stanganelli I Farnetani F Borsari S Mazzoni L Ciardo S Raucci M Magi S Bassoli S Spadafora M Mandel VD Casari A Chester J Kaleci S Colombo GL Pellacani G Cost–Benefit Analysis of in vivo Reflectance Confocal Microscopy for Melanoma Diagnosis in a Real-World Clinical Setting Risk Management and Healthcare Policy melanoma skin cancer diagnosis non-invasive diagnosis imaging techniques skin imaging reflectance confocal microscopy dermatoscopy dermoscopy number needed to excise follow-up randomized trial. |
| title | Cost–Benefit Analysis of in vivo Reflectance Confocal Microscopy for Melanoma Diagnosis in a Real-World Clinical Setting |
| title_full | Cost–Benefit Analysis of in vivo Reflectance Confocal Microscopy for Melanoma Diagnosis in a Real-World Clinical Setting |
| title_fullStr | Cost–Benefit Analysis of in vivo Reflectance Confocal Microscopy for Melanoma Diagnosis in a Real-World Clinical Setting |
| title_full_unstemmed | Cost–Benefit Analysis of in vivo Reflectance Confocal Microscopy for Melanoma Diagnosis in a Real-World Clinical Setting |
| title_short | Cost–Benefit Analysis of in vivo Reflectance Confocal Microscopy for Melanoma Diagnosis in a Real-World Clinical Setting |
| title_sort | cost ndash benefit analysis of in vivo reflectance confocal microscopy for melanoma diagnosis in a real world clinical setting |
| topic | melanoma skin cancer diagnosis non-invasive diagnosis imaging techniques skin imaging reflectance confocal microscopy dermatoscopy dermoscopy number needed to excise follow-up randomized trial. |
| url | https://www.dovepress.com/costbenefit-analysis-of-in-vivo-reflectance-confocal-microscopy-for-me-peer-reviewed-fulltext-article-RMHP |
| work_keys_str_mv | AT brunogm costndashbenefitanalysisofinvivoreflectanceconfocalmicroscopyformelanomadiagnosisinarealworldclinicalsetting AT dimatteos costndashbenefitanalysisofinvivoreflectanceconfocalmicroscopyformelanomadiagnosisinarealworldclinicalsetting AT longoc costndashbenefitanalysisofinvivoreflectanceconfocalmicroscopyformelanomadiagnosisinarealworldclinicalsetting AT stanganellii costndashbenefitanalysisofinvivoreflectanceconfocalmicroscopyformelanomadiagnosisinarealworldclinicalsetting AT farnetanif costndashbenefitanalysisofinvivoreflectanceconfocalmicroscopyformelanomadiagnosisinarealworldclinicalsetting AT borsaris costndashbenefitanalysisofinvivoreflectanceconfocalmicroscopyformelanomadiagnosisinarealworldclinicalsetting AT mazzonil costndashbenefitanalysisofinvivoreflectanceconfocalmicroscopyformelanomadiagnosisinarealworldclinicalsetting AT ciardos costndashbenefitanalysisofinvivoreflectanceconfocalmicroscopyformelanomadiagnosisinarealworldclinicalsetting AT rauccim costndashbenefitanalysisofinvivoreflectanceconfocalmicroscopyformelanomadiagnosisinarealworldclinicalsetting AT magis costndashbenefitanalysisofinvivoreflectanceconfocalmicroscopyformelanomadiagnosisinarealworldclinicalsetting AT bassolis costndashbenefitanalysisofinvivoreflectanceconfocalmicroscopyformelanomadiagnosisinarealworldclinicalsetting AT spadaforam costndashbenefitanalysisofinvivoreflectanceconfocalmicroscopyformelanomadiagnosisinarealworldclinicalsetting AT mandelvd costndashbenefitanalysisofinvivoreflectanceconfocalmicroscopyformelanomadiagnosisinarealworldclinicalsetting AT casaria costndashbenefitanalysisofinvivoreflectanceconfocalmicroscopyformelanomadiagnosisinarealworldclinicalsetting AT chesterj costndashbenefitanalysisofinvivoreflectanceconfocalmicroscopyformelanomadiagnosisinarealworldclinicalsetting AT kalecis costndashbenefitanalysisofinvivoreflectanceconfocalmicroscopyformelanomadiagnosisinarealworldclinicalsetting AT colombogl costndashbenefitanalysisofinvivoreflectanceconfocalmicroscopyformelanomadiagnosisinarealworldclinicalsetting AT pellacanig costndashbenefitanalysisofinvivoreflectanceconfocalmicroscopyformelanomadiagnosisinarealworldclinicalsetting |